MAPT and Parkinson disease: No differences were observed in CSF biomarkers p-tau181 or total tau (P > 0.05, two-sided Student’s t test), although CSF Aβ42/Aβ40 was slightly higher in the PD group (P < 0.05, two-sided Student’s t test).